Publications by Medical Specialty - Endocrinology, Diabetes & Metabolism

These publications were authored or co-authored by Quest Diagnostics staff.

SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels

Authors: Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF
PLoS One. 2020 Sep 17;15(9):e0239252. doi: 10.1371/journal.pone.0239252. eCollection 2020.

Specialties: Endocrinology, Diabetes & Metabolism, Infectious Disease

Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring

Authors: Fragala MS, Kaufman HW, Meigs JB, Niles JK, McPhaul MJ
Popul Health Manag. 2020 Jun 30; doi: 10.1089/pop.2020.0134 [Online ahead of print.]

Specialties: Endocrinology, Diabetes & Metabolism, Infectious Disease

Read the Key Summary (Download PDF)

Simultaneous Consideration of HbA 1c and Insulin Resistance Improves Risk Assessment in White Individuals at Increased Risk for Future Type 2 Diabetes

Authors: Meigs JB, Porneala B, Leong A, Shiffman D, Devlin JJ, McPhaul MJ.
Diabetes Care. 2020 Jun 12;dc200718. doi: 10.2337/dc20-0718. [Online ahead of print.]

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care.

Authors: Shiffman D, Louie JZ, Devlin JJ, Knowles JW, McPhaul MJ
J Am Heart Assoc. 2020 May 5;9:e015807. doi: 10.1161/JAHA.119.015807. Epub 2020 Apr 22.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors: Farukhi ZM, Demler OV, Caulfield MP, Kulkarni K, Wohlgemuth J, Cobble M, Luttmann-Gibson H, Li C, Nelson JR, Cook NR, Buring JE, Krauss RM, Manson JE, Mora S.
J Clin Lipidol. 2020 Mar - Apr;14(2):241-251. doi: 10.1016/j.jacl.2020.02.005. Epub 2020 Feb 21.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients.

Authors: Alcivar-Franco D, Purvis S, Penn MS, Klemes A
J Int Med Res. 2020 Jan;48(1):300060517749111.Epub 2018 Jan 31.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Disclaimer: One or more of the authors of this publication were employed at the time by Cleveland HeartLab, a subsidiary of Quest Diagnostics.

Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients.

Authors: Alcivar-Franco D, Purvis S, Penn MS, Klemes A
J Int Med Res. 2020 Jan;48(1):300060517749111. doi: 10.1177/0300060517749111. Epub 2018 Jan 31.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Disclaimer: One or more of the authors of this publication were employed at the time by Cleveland HeartLab, a subsidiary of Quest Diagnostics.

Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients.

Authors: Alcivar-Franco D, Purvis S, Penn MS, Klemes A
J Int Med Res. 2020 Jan;48(1):300060517749111. doi: 10.1177/0300060517749111.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Disclaimer: One or more of the authors of this publication were employed at the time by Cleveland HeartLab, a subsidiary of Quest Diagnostics.